K

Kriya Therapeutics

Develops gene therapies; licenses collaborations

Scientist 1 - Analytical Development

Bioprocess & BiomanufacturingUpdated on Nov 14
Full-timeMorrisville, NC, USANo salary listed

About the Job

Requirements

  • A relevant degree and working experience in a pharmaceutical, biotechnology, or CRO laboratory setting, meeting one of the following: a Bachelor's degree with 6 or more years of work experience; a Master's degree with 2 or more years of work experience; or a PhD degree or equivalent with 0 or more years of work experience.
  • State-of-the-industry analytical knowledge.
  • Experience working in a multidisciplinary team environment.
  • Flexible work hours and willingness to work outside normal schedule hours as necessary.
  • Ability to work in a laboratory setting, including extended periods standing, sitting, and using laboratory equipment; some lifting may be required.
  • Ability to follow proper handling and disposal procedures when working with chemicals or biological materials.

Responsibilities

  • Independently design, execute, and interpret studies to develop and optimize analytical methods for AAV products.
  • Seek out and analyze data from a variety of sources to support decision-making.
  • Author and review electronic laboratory notebook (ELN) entries and documents supporting analytical development activities as needed.
  • Routinely execute test methods supporting process development and development vector characterization.
  • Support Quality Control with analytical test method qualification and identify needs for release testing.
  • Collaborate with other scientists and routinely present data.
  • Perform other job-related duties as necessary.

Desired Qualifications

  • At least 2 years of experience developing and executing molecular assays, such as ddPCR and next-generation sequencing (NGS), for AAV gene therapies and/or protein therapeutics.

About the Company

Kriya Therapeutics

Develops gene therapies; licenses collaborations

Kriya Therapeutics develops gene therapies for widespread diseases and monetizes these programs through licensing and collaboration agreements. Its gene therapies target genetic or biological drivers of conditions such as Geographic Atrophy, Diabetic Retinopathy, and NASH, with a focus on ophthalmology. The company advances programs by partnering with biotech and pharma companies to secure upfront payments, milestones, and potential royalties. Its goal is to become a leading gene therapy biopharmaceutical company by delivering safe, effective treatments and generating revenue through collaborations and eventual product sales.

Company size
201-500
Company stage
Series D
Total funding
$920.5M
Headquarters
Morrisville, NC
Founded
2019

Recently Posted Jobs

Explore more opportunities at Kriya Therapeutics

See more jobs